Cargando…
Betatrophin: The long awaited circulating factor from the liver promoting β-cell replication?
Regenerative therapy in diabetes with the capacity to reconstitute a functional β-cell mass sufficient for glycemic control holds the promise to effectively prevent the development of devastating late complications due to the unique ability of the β-cell to sense and regulate blood-glucose levels. A...
Autores principales: | Ahnfelt-Rønne, Jonas, Madsen, Ole D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594198/ https://www.ncbi.nlm.nih.gov/pubmed/25483956 http://dx.doi.org/10.4161/isl.28686 |
Ejemplares similares
-
A Long-Awaited Structure Is Rev-ealed
por: Hammarskjold, Marie-Louise, et al.
Publicado: (2011) -
Betatrophin Versus Bitter-Trophin and the Elephant in the Room: Time for a New Normal in β-Cell Regeneration Research
por: Stewart, Andrew F.
Publicado: (2014) -
Renal function is independently associated with circulating betatrophin
por: Maurer, Lukas, et al.
Publicado: (2017) -
Commentary: In the aftermath, what awaits us?
por: Klapper, Jacob A.
Publicado: (2022) -
Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes
por: Espes, Daniel, et al.
Publicado: (2013)